EP-100

N/A

Report date: 2023/04/13 16:00:41
NME

Base Information

Drug NameEP-100
Drug Alias NamePhor18-LHRHEP-100
ClassificationSmall molecules > Synthetic peptide > Peptide drug conjugate (PDC)
Mechanisms of ActionCell membrane permeability enhancersAnti-GnRHR
TargetsGonadotropin-releasing hormone receptor
Therapy Area/IndicationsSolid tumoursOvarian Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesEsperance Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEsperance Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsSolid tumoursOvarian Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A